MENLO
PARK, Calif., Aug. 30,
2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL),
a healthcare company whose mission is to detect cancer early when
it can be cured, today announced that it has granted equity awards
in the form of restricted stock units ("RSUs") underlying an
aggregate of 182,223 shares of GRAIL's common stock to 55
recently hired non-executive employees as an inducement material to
their acceptance of employment with GRAIL. The employment
inducement awards were granted under GRAIL's Inducement Equity
Incentive Plan and related form of restricted stock award agreement
in accordance with Nasdaq Listing Rule 5635(c)(4).
The inducement plan is used exclusively for the grant of equity
awards to individuals who were not previously employees of GRAIL,
or following a bona fide period of non-employment, as an inducement
material to such individuals entering into employment with GRAIL,
pursuant to Nasdaq Listing Rule 5635(c)(4).
The RSUs vest over an approximately four year period, with
25% of the award vesting in either May or August, 2025, depending
on the start date of the employee, and on each one year anniversary
of those respective dates thereafter, subject to continued
employment with GRAIL (or any successor to or subsidiary of the
Company) through the vesting dates.
About GRAIL
GRAIL is a healthcare company whose
mission is to detect cancer early, when it can be cured. GRAIL is
focused on alleviating the global burden of cancer by using the
power of next-generation sequencing, population-scale clinical
studies, and state-of-the-art machine learning, software, and
automation to detect and identify multiple deadly cancer types in
earlier stages. GRAIL's targeted methylation-based platform can
support the continuum of care for screening and precision oncology,
including multi-cancer early detection in symptomatic patients,
risk stratification, minimal residual disease detection, biomarker
subtyping, treatment and recurrence monitoring. GRAIL is
headquartered in Menlo Park, CA
with locations in Washington,
D.C., North Carolina, and
the United Kingdom.
For more information, visit grail.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/grail-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-302235336.html
SOURCE GRAIL, Inc.
